Last Updated: June 11, 2021
Result type: Reports
Generic Name: romosozumab
Indications: The treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture.
Last Updated: June 11, 2021
Result type: Reports
Generic Name: incobotulinumtoxinA
Indications: For the treatment of chronic sialorrhea associated with neurological disorders in adults.
Last Updated: December 24, 2020
Result type: Reports
Generic Name: liraglutide
Indications: Saxenda® (liraglutide) is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of: 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbidity (e.g., hypertension, type 2 diabetes, or dyslipidemia) and who have failed a previous weight management intervention.
Last Updated: June 10, 2021
Result type: Reports
Generic Name: lorlatinib
Indications:
Monotherapy for the first-line treatment of adult
patients with anaplastic lymphoma kinase (ALK)-positive locally advanced (not
amenable to curative therapy) or metastatic non-small cell lung cancer (NSCLC)
Last Updated: June 9, 2021
Result type: Reports
Generic Name: luspatercept
Indications: Reblozyl (luspatercept for injection) is indicated for: the treatment of adult patients with red blood cell (RBC) transfusion-dependent anemia associated with beta(β)-thalassemia. the treatment of adult patients with transfusion-dependent anemia requiring at least two RBC units over 8 weeks resulting from very low- to intermediate-risk myelodysplastic syndromes (MDS) who have ring sideroblasts and who have failed or are not suitable for erythropoietin-based therapy.
Last Updated: June 9, 2021
Result type: Reports
Generic Name: upadacitinib
Indications: Rinvoq is indicated for the treatment of adults with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate or other DMARDs.. Rinvoq may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs).
Last Updated: December 22, 2020
Result type: Reports
Generic Name: brexucabtagene autoleucel
Indications: For the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after two or more lines of systemic therapy including a Bruton’s tyrosine kinase (BTK) inhibitor.
Last Updated: June 9, 2021
Result type: Reports
Generic Name: zanubrutinib
Indications: For the treatment of patients with Waldenström’s macroglobulinemia (WM)
Last Updated: March 12, 2021
Result type: Reports
Generic Name: dinutuximab
Indications: For
the treatment of high-risk neuroblastoma patients in their first relapse or
determination of refractory disease, in combination with irinotecan,
temozolomide, and granulocyte macrophage colony-stimulating factor.
Last Updated: December 21, 2020
Result type: Reports
Generic Name: encorafenib and binimetinib
Indications: Braftovi (encorafenib): In combination with binimetinib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600 mutation, as detected by a validated test. Mektovi (binimetinib): In combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600 mutation, as detected by a validated test.
